Knowledge Driven Oncology.

 

LIFE Biosystems is an in silico-driven biotechnology company dedicated to maximizing the clinical success of new and approved oncology drugs. Collaborating with comprehensive cancer centers and the biopharmaceutical industry, LIFE is focused on discovering personalized approaches for the early identification and appropriate treatment of non-responsive cancer patients. Strong partnering combined with computational excellence enables us to optimize the clinical positioning of anti-cancer drugs. By rationally defining appropriate molecular contexts for these therapies, we are inspired by the promise of personalized patient care.

 

 

Latest News

07-10-08 18:49

LIFE Biosystems to Deploy TEMIS’ Information Discovery Solution Luxid®.

Luxid® to enhance LIFE’s proprietary in silico discovery infrastructure to provide enhanced data-mining capabilities in the field of predictive medicine. [more...]

03-09-08 10:16

LIFE Biosystems and the Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Collaborate to Advance the Clinical Application of Information Extraction Technologies.

Collaboration to provide important innovations in the field of clinical data extraction and therapeutic system modelling. [more...]

23-04-08 14:00

LIFE Biosystems AG Establishes Strategic Affiliation with the University of Texas M.D. Anderson Cancer Center

LIFE Biosystems receives exclusive rights to commercialize intellectual property discovered in certain joint research projects. [more...]

23-04-08 14:00

LIFE Biosystems to Provide Strategic IT Consulting to M. D. Anderson Cancer Center

Replacement of the existing Clinical Trial Protocol Data Management System (PDMS) with an updated Comprehensive Protocol Management Solution. [more...]